BOULDER, Colo., July 6, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cantor Fitzgerald 2015 Healthcare Conference in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: | Cantor Fitzgerald 2015 Healthcare Conference |
Presenter: | Ron Squarer, Chief Executive Officer |
Date: | Wednesday, July 8, 2015 |
Time: | 1:00 p.m. Eastern Time |
Webcast: |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently advancing. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.
CONTACT: | Tricia Haugeto |
Array BioPharma Inc. | |
303-386-1193 | |
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-cantor-fitzgerald-2015-healthcare-conference-300109222.html
SOURCE Array BioPharma Inc.
Help employers find you! Check out all the jobs and post your resume.
